From our Chief of Staff

Ever since its inception, the Sheba Medical Center at Tel Hashomer has placed a premium on being on the cusp of medical innovation and being able to offer patients groundbreaking and advanced medical solutions. We at Sheba invest heavily in research and our researchers; our doctors attend training sessions and complete fellowships at the most progressive medical centers in the world, the ones that lead the way in medical breakthroughs. Our researchers play a major role in generating new lifesaving treatments, and the research we take part in is destined to change medicine as we know it.

Our T-Car treatment is a prime example of how Sheba lives up to its research aspirations. When medical institutions in the United States started experimenting with T-CAR treatments on children and young adults with leukemia, we at Sheba led the way in implementing these treatments -  from the very beginning, it was extremely clear to us that we would offer this unique treatment to our patients, especially in cases in which all other treatments had failed.

It's not that we simply joined a larger experiment - we insisted on bringing the T-CAR technology in-house, a large investment for the hospital. In this way, we're not dependent on outside sources to produce the necessary cells. The ability to produce the T-cells in a Sheba lab is what has enabled us to treat and help - up until this point - dozens of patients who desperately needed this treatment. Sheba is the first and only medical center in Israel that offers this treatment in-house, with a more than 75% success rate.

With our patients in mind, we'll always be on the forefront of medicine, armed with the latest research and determined to move forward with the science and to develop innovative treatments that make a real impact.